← ANALYSTS · TIPRANKS

Serge Belanger · Needham

#674among 12,504 TipRanks analysts★★★★★★★★★★
Hits 49% 244 of 503 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating +14.9% Over a year after the rating, TipRanks’ measure
Our companies rated now 20 Buy / hold / sell: 15 / 5 / 0
Upside of the analyst’s targets +135.0% Average over 16 current targets, to the last price
The market’s answer to the ratings +1.4% Day-0 move against SPY in the rating’s direction, average over 6 upgrades, downgrades and target changes
Date · added, NYStockAction RatingPrice target Upside Move vs SPY
Oct 14on TipRanks 07:30 LQDAIWMLiquidia Technologies · $3.1B Reiterated Buy $72.00 → $58.00−19.4% +68.9% +27.7%next day +2.2%
Oct 8on TipRanks 11:45 PCRXIWMPacira Pharmaceuticals · $1.4B Downgrade Hold — — +44.8%next day −0.8% · 5 days +0.1%
Oct 5on TipRanks 06:25 CYTKIWMCytokinetics · $8.9B Reiterated Buy $112 +80.8% −5.1%next day −2.7% · 5 days −0.3%
Sep 28on TipRanks 14:25 OCULIWMOcular Therapeutix · $1.6B Reiterated Buy $18.00 +162.0% −19.9%next day +3.0% · 5 days −6.5%
Sep 18on TipRanks 06:35 XENEIWMXenon · $3.3B Reiterated Buy $78.00 → $60.00−23.1% +79.2% −30.8%next day −3.5% · 5 days −8.3%
Sep 9on TipRanks 09:35 EVMNIWMEvommune, Inc. · $215M Reiterated Buy $28.00 +441.6% −16.7%next day −2.0% · 5 days −12.5%
Sep 8on TipRanks 13:15 BCRXIWMBioCryst · $2.0B Reiterated Buy $16.00 +105.4% −8.4%next day −2.4% · 5 days −8.9%
Aug 13on TipRanks 13:25 CRMDIWMCormedix · $581M Reiterated Buy $15.00 +106.6% +14.0%next day −7.2% · 5 days +3.1%
Aug 13on TipRanks 05:55 OMERIWMOmeros · $1.3B Reiterated Hold — — +25.9%next day −0.7% · 5 days +9.3%
Aug 12on TipRanks 14:15 MANEIWMVeradermics, Incorporated · $4.8B Reiterated Buy $164 +50.7% −0.2%next day +1.1% · 5 days +2.4%
Aug 10on TipRanks 12:55 MLTXMoonLake Immunotherapeutics · $873M Reiterated Buy $30.00 +214.1% −5.1%next day −3.9% · 5 days −5.6%
Aug 10on TipRanks 12:10 HRTXIWMHeron Therapeutics · $69M Reiterated Hold — — −31.6%next day −3.3% · 5 days −4.4%
Aug 7on TipRanks 17:50 NAMSNewAmsterdam Pharma Company · $2.4B Reiterated Buy $48.00 +142.1% +0.1%next day −1.0% · 5 days −3.8%
Aug 7on TipRanks 17:15 TRVIIWMTrevi Therapeutics · $1.7B Reiterated Buy $23.00 +93.6% −3.8%next day +0.3% · 5 days +3.9%
Aug 7on TipRanks 14:50 OCSOculis Holding · $486M Reiterated Buy $38.00 +421.3% +1.8%next day +0.7% · 5 days +1.7%
Aug 7on TipRanks 08:20 AMPHIWMAmphastar Pharmaceuticals · $1.1B Reiterated Hold $20.00 −22.7% +4.3%next day −2.2% · 5 days +0.2%
Aug 6on TipRanks 14:10 COLLIWMCollegium Pharmaceutical · $733M Reiterated Buy $56.00 → $46.00−17.9% +98.4% −18.4%next day +0.6% · 5 days −4.5%
Aug 6on TipRanks 09:15 VRDNIWMViridian Therapeutics · $2.2B Reiterated Buy $34.00 +78.7% +7.0%next day +4.2% · 5 days −3.5%
Aug 6on TipRanks 07:11 EOLSIWMEvolus · $500M Reiterated Hold — — +20.1%next day +1.8% · 5 days +7.0%
Aug 6on TipRanks 06:50 ARQTIWMArcutis Biotherapeutics · $3.7B Assigned Buy $40.00 +38.8% −2.3%next day −4.9% · 5 days −3.5%

Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗